Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kunpeng Shu"'
Publikováno v:
Electronic Journal of Biotechnology, Vol 43, Iss , Pp 32-40 (2020)
Background: TP73 antisense RNA 1 (TP73-AS1), a newly discovered long non-coding RNA (lncRNA), has been reported to be upregulated in various kinds of tumors, and shows a variable influence on living quality and prognosis of patients. Thus, we conduct
Externí odkaz:
https://doaj.org/article/9c2645dd3062467a9779b8bf2af79f50
Autor:
Xingming Zhang, Xiaoxue Yin, Haoran Zhang, Guangxi Sun, Yaojing Yang, Junru Chen, Kunpeng Shu, Jinge Zhao, Peng Zhao, Ni Chen, Jia Wang, Pengfei Shen, Hao Zeng
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Due to the significant heterogeneity of renal cell carcinoma (RCC), immune checkpoints may express differently between primary and metastatic tumor. We aimed to evaluate the differential expression of TIM-3 between the primary and
Externí odkaz:
https://doaj.org/article/479a96f646554afe9839dd76ca5167d2
Autor:
Jun Zhou, Linlin Li, Xing Li, Qian Yu, Shaowei Cui, Kunpeng Shu, Jianjun Liu, Jie Liu, Degang Ding, Tao Du
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 1, Pp 867-874 (2019)
Objective: To compare the efficacy and safety of a novel thermochemotherapy scheme and the instillation of pirarubicin (THP) without hyperthermia in patients with intermediate- and high-risk nonmuscle-invasive bladder cancer (NMIBC). Materials and me
Externí odkaz:
https://doaj.org/article/7fe34a26323f4631bc40af782f257531
Autor:
Kunpeng Shu, Peng Zhao, Jinge Zhao, Guangxi Sun, Yaojing Yang, Hao Zeng, Qidun Tang, Pengfei Shen, Jiandong Liu, Junru Chen, Jia Wang, Xingming Zhang
Publikováno v:
Journal of Cancer. 9:3303-3310
Purpose: This study aimed to identify the survival benefit and safety of alternative dosage schedules for sunitinib in metastatic renal cell carcinoma. Materials and Methods: Clinicopathologic and survival data of patients treated with sunitinib as f
Autor:
Xingming Zhang, Hao Zeng, Xiaoxue Yin, Qidun Tang, Rui Huang, Guangxi Sun, Kunpeng Shu, Ni Chen, Jiandong Liu, Jinge Zhao, Jing Gong, Pengfei Shen
Publikováno v:
The Prostate. 77:1279-1287
Background: Perineural invasion (PNI) is a distinct pathologic entity and a recognized source of tumor spread. However, the role of PNI in high-risk prostate cancer (PCa) has not been explored. The aims of the study were to investigate the impact of
Autor:
Hao Zeng, Yaojing Yang, Pengfei Shen, Guangxi Sun, Xingming Zhang, Jing Gong, Jiang-Dong Liu, Haojun Gui, Xueqin Chen, Ni Chen, Jinge Zhao, Kunpeng Shu
Publikováno v:
Asian Journal of Andrology, Vol 19, Iss 5, Pp 573-578 (2017)
Asian Journal of Andrology
Asian Journal of Andrology
We compared the predictive ability of the 2014 and 2005 Gleason grading systems in 568 patients initially diagnosed with metastatic prostate cancer (PCa). Outcomes included the duration of castration-resistant prostate cancer-free survival (CFS) and
Autor:
Kunpeng Shu, Xing Li, Jun Zhou, Shaowei Cui, Jianjun Liu, Linlin Li, Tao Du, Degang Ding, Jie Liu, Qian Yu
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 1, Pp 867-874 (2019)
Objective: To compare the efficacy and safety of a novel thermochemotherapy scheme and the instillation of pirarubicin (THP) without hyperthermia in patients with intermediate- and high-risk nonmuscle-invasive bladder cancer (NMIBC). Materials and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d6580449c36317cd49cd391de01c0ea
Autor:
Jing Gong, Xiuyi Pan, Qidun Tang, Xiaoxue Yin, Kunpeng Shu, Junya Tan, Hao Zeng, Ni Chen, Xingming Zhang, Pengfei Shen
Publikováno v:
The Prostate. 76:823-833
BACKGROUND SPINK1 has been described to be mutually exclusively expressed in prostate cancer (PCa), but its expression profiles and the probable roles in bone metastatic PCa have not been thoroughly explored. METHODS Total of 155 biopsy specimens fro
Publikováno v:
Clinical Genitourinary Cancer. 18:11-19.e1
To assess the ability of preoperative plasma fibrinogen and D-dimer as biomarkers to predict survival outcomes in patients with non-muscle-invasive bladder cancer (NMIBC).A total of 206 NMIBC patients receiving transurethral resection of bladder tumo
Autor:
Haoran Zhang, Guangxi Sun, Peng Zhao, Ni Chen, Jinge Zhao, Jia Wang, Yaojing Yang, Pengfei Shen, Hao Zeng, Kunpeng Shu, Xingming Zhang, Xiaoxue Yin, Junru Chen
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Background Due to the significant heterogeneity of renal cell carcinoma (RCC), immune checkpoints may express differently between primary and metastatic tumor. We aimed to evaluate the differential expression of TIM-3 between the primary and metastat